S256: TABELECLEUCEL FOR EBV-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOTHERAPY (ALLELE)

Authors: S. Prockop, A. Beitinjaneh, S. Choquet, S. Dahiya, R. Dinavahi, R. Farah, L. Gamelin, A. Ghobadi, A. Mehta, P. Nayak, R. Reshef, G. Satyanarayana, P. Stiff, W. Ye, K. M. Mahadeo

Published: 2022-06-23

DOI: 10.1097/01.hs9.0000843916.04522.0a

Source: Full article

---

Abstract

No abstract found.